Randomized phase II-III study of matrix metalloproteinase inhibitor (MMPI) BMS-275291 in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC): NCIC-CTG BR. 18.

Document type:: Meeting Abstract
Author(s):: Leighl, NB; Shepherd, F; Paz-Ares, L; Douillard, JY; Peschel, C; Arnold, A; Tu, D; Galbraith, S; Hann, K; Seymour, L
Title:: Randomized phase II-III study of matrix metalloproteinase inhibitor (MMPI) BMS-275291 in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC): NCIC-CTG BR. 18.
Journal title abbreviation:: J Clin Oncol
Year:: 2004
Journal volume:: 22 Suppl.
Journal issue:: 14
Pages contribution:: 626S-626S
Language:: eng
Print-ISSN:: 0732-183X
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: